A Study of CRD3874-SI in People With Solid Tumors

NCT06021626 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Merkel Cell Carcinoma

Interventions

DRUG: CRD3874

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]